Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Research Personnel | 2 | 2018 | 191 | 0.460 |
Why?
|
| Information Storage and Retrieval | 1 | 2011 | 35 | 0.360 |
Why?
|
| Leptin | 3 | 2017 | 118 | 0.340 |
Why?
|
| Internet | 1 | 2011 | 234 | 0.300 |
Why?
|
| Sarcoidosis | 1 | 2007 | 11 | 0.260 |
Why?
|
| Comorbidity | 4 | 2007 | 725 | 0.250 |
Why?
|
| Receptors, Notch | 2 | 2017 | 37 | 0.230 |
Why?
|
| Lung | 1 | 2007 | 484 | 0.210 |
Why?
|
| Georgia | 5 | 2019 | 189 | 0.170 |
Why?
|
| Information Dissemination | 2 | 2014 | 66 | 0.160 |
Why?
|
| Health Services Accessibility | 4 | 2011 | 680 | 0.160 |
Why?
|
| Hypertension | 4 | 2011 | 823 | 0.160 |
Why?
|
| Peer Review, Research | 1 | 2018 | 15 | 0.150 |
Why?
|
| Personnel Selection | 1 | 2018 | 12 | 0.140 |
Why?
|
| Research Support as Topic | 1 | 2018 | 89 | 0.140 |
Why?
|
| Government Programs | 1 | 2018 | 29 | 0.140 |
Why?
|
| Obesity | 3 | 2017 | 1131 | 0.140 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2011 | 45 | 0.140 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 163 | 0.140 |
Why?
|
| Receptor, Notch1 | 1 | 2017 | 15 | 0.130 |
Why?
|
| Interleukin-1 | 1 | 2017 | 39 | 0.130 |
Why?
|
| Humans | 29 | 2019 | 42163 | 0.130 |
Why?
|
| Primary Health Care | 4 | 2009 | 362 | 0.130 |
Why?
|
| Aspirin | 1 | 2017 | 88 | 0.130 |
Why?
|
| Endometrial Neoplasms | 1 | 2017 | 79 | 0.120 |
Why?
|
| Schools, Medical | 2 | 2011 | 208 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 94 | 0.120 |
Why?
|
| Renal Dialysis | 2 | 2008 | 124 | 0.120 |
Why?
|
| Middle Aged | 15 | 2017 | 11819 | 0.110 |
Why?
|
| Computer Communication Networks | 1 | 2014 | 12 | 0.110 |
Why?
|
| Disease Progression | 3 | 2017 | 661 | 0.110 |
Why?
|
| Minority Groups | 2 | 2018 | 663 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 206 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 73 | 0.100 |
Why?
|
| Electronic Health Records | 1 | 2014 | 99 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2017 | 2111 | 0.100 |
Why?
|
| Female | 18 | 2018 | 24018 | 0.100 |
Why?
|
| Male | 17 | 2018 | 22779 | 0.100 |
Why?
|
| Health Promotion | 2 | 2010 | 691 | 0.090 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2011 | 5 | 0.090 |
Why?
|
| Socioeconomic Factors | 2 | 2007 | 1221 | 0.090 |
Why?
|
| PubMed | 1 | 2011 | 5 | 0.090 |
Why?
|
| Informatics | 1 | 2011 | 3 | 0.090 |
Why?
|
| Registries | 3 | 2019 | 431 | 0.090 |
Why?
|
| Search Engine | 1 | 2011 | 7 | 0.090 |
Why?
|
| Pulmonary Artery | 1 | 2011 | 33 | 0.090 |
Why?
|
| Heart-Assist Devices | 1 | 2011 | 37 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 933 | 0.090 |
Why?
|
| Community Health Centers | 2 | 2009 | 56 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2011 | 2485 | 0.090 |
Why?
|
| Remote Consultation | 1 | 2010 | 8 | 0.080 |
Why?
|
| Adult | 12 | 2011 | 13458 | 0.080 |
Why?
|
| Urban Population | 2 | 2010 | 364 | 0.080 |
Why?
|
| Coronary Angiography | 2 | 2011 | 97 | 0.080 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2010 | 65 | 0.080 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2010 | 33 | 0.080 |
Why?
|
| Biomedical Research | 2 | 2011 | 467 | 0.080 |
Why?
|
| Disease Management | 1 | 2010 | 68 | 0.080 |
Why?
|
| Aged | 10 | 2017 | 7982 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 85 | 0.080 |
Why?
|
| Focus Groups | 1 | 2011 | 398 | 0.070 |
Why?
|
| Healthcare Disparities | 2 | 2011 | 573 | 0.070 |
Why?
|
| Community Networks | 2 | 2006 | 106 | 0.070 |
Why?
|
| Medically Uninsured | 1 | 2009 | 64 | 0.070 |
Why?
|
| Rural Health Services | 1 | 2009 | 47 | 0.070 |
Why?
|
| Treatment Refusal | 1 | 2008 | 23 | 0.070 |
Why?
|
| Health Behavior | 2 | 2010 | 568 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 242 | 0.070 |
Why?
|
| Appointments and Schedules | 1 | 2008 | 27 | 0.070 |
Why?
|
| Qualitative Research | 1 | 2011 | 526 | 0.070 |
Why?
|
| Health Literacy | 1 | 2010 | 120 | 0.070 |
Why?
|
| Quality of Health Care | 2 | 2005 | 158 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2009 | 541 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2007 | 708 | 0.070 |
Why?
|
| Radiography | 1 | 2007 | 72 | 0.070 |
Why?
|
| Students, Medical | 1 | 2009 | 153 | 0.060 |
Why?
|
| Erythropoiesis | 1 | 2006 | 11 | 0.060 |
Why?
|
| Cross-Sectional Studies | 4 | 2010 | 3077 | 0.060 |
Why?
|
| Chemistry, Clinical | 1 | 2006 | 1 | 0.060 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2006 | 6 | 0.060 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2006 | 5 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2007 | 164 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2006 | 74 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2009 | 268 | 0.060 |
Why?
|
| Immunoglobulin M | 1 | 2006 | 87 | 0.060 |
Why?
|
| Logistic Models | 4 | 2011 | 1001 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2007 | 199 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2006 | 181 | 0.060 |
Why?
|
| Diffusion of Innovation | 1 | 2005 | 38 | 0.060 |
Why?
|
| Poverty Areas | 1 | 2005 | 46 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 456 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2005 | 98 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2005 | 141 | 0.060 |
Why?
|
| Risk Factors | 3 | 2011 | 3942 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2019 | 1574 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 2598 | 0.060 |
Why?
|
| Program Development | 2 | 2018 | 237 | 0.050 |
Why?
|
| Anemia, Sickle Cell | 1 | 2006 | 185 | 0.050 |
Why?
|
| Myocardium | 1 | 2006 | 251 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 134 | 0.050 |
Why?
|
| Chemokine CCL5 | 1 | 2004 | 40 | 0.050 |
Why?
|
| Malaria, Cerebral | 1 | 2004 | 30 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2009 | 585 | 0.050 |
Why?
|
| Blood Pressure | 4 | 2011 | 662 | 0.050 |
Why?
|
| Substance-Related Disorders | 2 | 2009 | 825 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2004 | 72 | 0.050 |
Why?
|
| Education, Medical | 1 | 2005 | 117 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2005 | 239 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2005 | 243 | 0.050 |
Why?
|
| Multivariate Analysis | 3 | 2011 | 638 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 250 | 0.050 |
Why?
|
| Time Factors | 3 | 2017 | 1848 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 1679 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 959 | 0.050 |
Why?
|
| United States | 4 | 2018 | 5072 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 309 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 744 | 0.050 |
Why?
|
| Heart Failure | 1 | 2005 | 298 | 0.040 |
Why?
|
| Asthma | 1 | 2005 | 410 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2017 | 1420 | 0.040 |
Why?
|
| Poverty | 3 | 2010 | 395 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 729 | 0.040 |
Why?
|
| Writing | 1 | 2018 | 41 | 0.040 |
Why?
|
| Financing, Organized | 1 | 2018 | 15 | 0.040 |
Why?
|
| Benchmarking | 1 | 2018 | 33 | 0.040 |
Why?
|
| Career Mobility | 1 | 2018 | 29 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 438 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2011 | 2803 | 0.030 |
Why?
|
| Diffusion | 1 | 2017 | 63 | 0.030 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2017 | 3 | 0.030 |
Why?
|
| Confidence Intervals | 2 | 2010 | 162 | 0.030 |
Why?
|
| Prevalence | 3 | 2008 | 1597 | 0.030 |
Why?
|
| Diamines | 1 | 2017 | 8 | 0.030 |
Why?
|
| Faculty | 1 | 2018 | 105 | 0.030 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2017 | 19 | 0.030 |
Why?
|
| Autocrine Communication | 1 | 2017 | 12 | 0.030 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2017 | 44 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2017 | 18 | 0.030 |
Why?
|
| Antibodies | 1 | 2017 | 140 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 139 | 0.030 |
Why?
|
| Thiazoles | 1 | 2017 | 76 | 0.030 |
Why?
|
| Health Surveys | 2 | 2009 | 401 | 0.030 |
Why?
|
| Endometrium | 1 | 2017 | 60 | 0.030 |
Why?
|
| Cultural Diversity | 1 | 2018 | 187 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 366 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2010 | 587 | 0.030 |
Why?
|
| Patient Education as Topic | 2 | 2010 | 234 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 256 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2017 | 403 | 0.030 |
Why?
|
| Ligands | 1 | 2017 | 387 | 0.030 |
Why?
|
| Nanostructures | 1 | 2017 | 158 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2017 | 348 | 0.030 |
Why?
|
| Water | 1 | 2017 | 314 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 273 | 0.030 |
Why?
|
| Organizations | 1 | 2014 | 8 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2011 | 1586 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 2005 | 225 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 43 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2013 | 42 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2013 | 34 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2013 | 80 | 0.030 |
Why?
|
| Adolescent | 3 | 2010 | 5950 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 100 | 0.020 |
Why?
|
| Sternotomy | 1 | 2011 | 2 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2011 | 12 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2011 | 23 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 428 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 40 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 236 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2011 | 111 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2013 | 267 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2011 | 362 | 0.020 |
Why?
|
| Chest Pain | 1 | 2011 | 49 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2011 | 92 | 0.020 |
Why?
|
| Telephone | 1 | 2010 | 35 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2011 | 206 | 0.020 |
Why?
|
| Echocardiography | 1 | 2011 | 167 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 548 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2011 | 184 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 640 | 0.020 |
Why?
|
| Research Design | 1 | 2011 | 370 | 0.020 |
Why?
|
| Social Class | 1 | 2011 | 286 | 0.020 |
Why?
|
| Domestic Violence | 1 | 2009 | 32 | 0.020 |
Why?
|
| Data Collection | 1 | 2010 | 210 | 0.020 |
Why?
|
| Curriculum | 1 | 2011 | 311 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2009 | 44 | 0.020 |
Why?
|
| Social Perception | 1 | 2009 | 71 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2009 | 152 | 0.020 |
Why?
|
| Young Adult | 2 | 2010 | 4936 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 1804 | 0.020 |
Why?
|
| Infant | 1 | 2011 | 1143 | 0.020 |
Why?
|
| Animals | 2 | 2017 | 16695 | 0.020 |
Why?
|
| C-Peptide | 1 | 2007 | 7 | 0.020 |
Why?
|
| Universities | 1 | 2011 | 539 | 0.020 |
Why?
|
| Fasting | 1 | 2007 | 56 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2007 | 73 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2007 | 99 | 0.020 |
Why?
|
| Triglycerides | 1 | 2007 | 146 | 0.020 |
Why?
|
| Child | 2 | 2006 | 3381 | 0.020 |
Why?
|
| Reticulocyte Count | 1 | 2006 | 3 | 0.020 |
Why?
|
| South Carolina | 1 | 2006 | 25 | 0.020 |
Why?
|
| Basal Metabolism | 1 | 2006 | 6 | 0.020 |
Why?
|
| Calorimetry, Indirect | 1 | 2006 | 9 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2008 | 487 | 0.020 |
Why?
|
| Blood Coagulation Tests | 1 | 2006 | 5 | 0.020 |
Why?
|
| North Carolina | 1 | 2006 | 122 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2006 | 111 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 56 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2006 | 112 | 0.020 |
Why?
|
| Motor Activity | 1 | 2009 | 438 | 0.020 |
Why?
|
| Homeostasis | 1 | 2007 | 193 | 0.020 |
Why?
|
| Medical Audit | 1 | 2006 | 26 | 0.020 |
Why?
|
| Nephrology | 1 | 2005 | 19 | 0.010 |
Why?
|
| Unemployment | 1 | 2005 | 27 | 0.010 |
Why?
|
| Flowmeters | 1 | 2005 | 1 | 0.010 |
Why?
|
| Insulin | 1 | 2007 | 255 | 0.010 |
Why?
|
| Metered Dose Inhalers | 1 | 2005 | 2 | 0.010 |
Why?
|
| Teaching Materials | 1 | 2005 | 10 | 0.010 |
Why?
|
| Financing, Government | 1 | 2005 | 20 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2005 | 58 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2007 | 386 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2006 | 112 | 0.010 |
Why?
|
| Heart Rate | 1 | 2006 | 261 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2005 | 144 | 0.010 |
Why?
|
| Mexican Americans | 1 | 2007 | 224 | 0.010 |
Why?
|
| Group Practice | 1 | 2005 | 8 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 2005 | 29 | 0.010 |
Why?
|
| Education | 1 | 2005 | 60 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2005 | 74 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 224 | 0.010 |
Why?
|
| Medically Underserved Area | 1 | 2005 | 118 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 249 | 0.010 |
Why?
|
| Receptors, CCR3 | 1 | 2004 | 10 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2005 | 108 | 0.010 |
Why?
|
| Receptors, CCR5 | 1 | 2004 | 64 | 0.010 |
Why?
|
| Educational Status | 1 | 2005 | 335 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 2009 | 634 | 0.010 |
Why?
|
| Alleles | 1 | 2005 | 352 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2005 | 225 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 454 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2007 | 916 | 0.010 |
Why?
|
| Community Health Services | 1 | 2005 | 207 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 261 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2009 | 641 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 1058 | 0.010 |
Why?
|
| Health Personnel | 1 | 2005 | 262 | 0.010 |
Why?
|
| Prognosis | 1 | 2005 | 850 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 6490 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 285 | 0.010 |
Why?
|
| Alcoholism | 1 | 2005 | 292 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 727 | 0.010 |
Why?
|
| Smoking | 1 | 2007 | 1019 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 860 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2004 | 1516 | 0.010 |
Why?
|
| Brain | 1 | 2004 | 1452 | 0.010 |
Why?
|